FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 64 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $562,000 | +136.1% | 168,778 | +68.8% | 0.04% | +150.0% |
| Q2 2019 | $238,000 | -92.9% | 100,000 | -88.8% | 0.02% | -91.5% |
| Q1 2019 | $3,334,000 | +459.4% | 889,000 | +754.8% | 0.19% | +347.6% |
| Q3 2018 | $596,000 | -65.9% | 104,000 | -34.1% | 0.04% | -63.8% |
| Q4 2016 | $1,750,000 | -51.3% | 157,700 | -59.4% | 0.12% | -42.9% |
| Q3 2016 | $3,593,000 | +14.0% | 388,000 | -21.9% | 0.20% | +23.0% |
| Q2 2016 | $3,153,000 | -15.0% | 496,547 | -12.8% | 0.16% | -28.3% |
| Q1 2016 | $3,711,000 | -21.1% | 569,180 | -1.9% | 0.23% | -52.6% |
| Q4 2015 | $4,704,000 | +35.2% | 580,000 | +22.2% | 0.48% | +62.8% |
| Q3 2015 | $3,480,000 | -16.2% | 474,810 | +17.2% | 0.30% | +18.3% |
| Q2 2015 | $4,151,000 | – | 405,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,000,000 | $7,330,000 | 3.56% |
| Sio Capital Management, LLC | 336,286 | $2,465,000 | 1.69% |
| Opaleye Management Inc. | 285,000 | $2,089,000 | 1.03% |
| SENZAR ASSET MANAGEMENT, LLC | 864,408 | $6,336,111,000 | 0.92% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,350,847 | $9,902,000 | 0.74% |
| Ghost Tree Capital, LLC | 150,000 | $1,100,000 | 0.50% |
| PURA VIDA INVESTMENTS, LLC | 102,000 | $748,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $2,785,000 | 0.36% |
| J. Goldman & Co LP | 474,810 | $3,480,000 | 0.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $6,956,000 | 0.27% |